Clinical Trial Update: Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh [Phase 4]

View source ↗

Summary

Phase 4 real-world evaluation study of Omarigliptin for Type 2 diabetes mellitus in Bangladesh, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Omarigliptin (omarigliptin)

Snippet

Sponsor: Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders | Conditions: Type2diabetes | Phase 4 | Status: NOT_YET_RECRUITING